Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities - PubMed (original) (raw)
. 1991 Dec 5;266(34):23128-34.
Affiliations
- PMID: 1744111
Free article
Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities
I Clark-Lewis et al. J Biol Chem. 1991.
Free article
Abstract
Interleukin-8 (IL-8) is an inflammatory mediator that stimulates neutrophil migration and functional activation. Analogs of human IL-8 were chemically synthesized, purified, and compared with the full-length 72-residue synthetic IL-8 for their ability to stimulate neutrophil chemotaxis and exocytosis as measured by assaying for release of elastase, as well as their binding to specific receptors in competition assays. Analogs corresponding to the less abundant natural forms, 3-72, 4-72, and 77-residue IL-8, were evaluated and the 3-72 and 4-72 had 2-5-fold higher potencies, whereas the 77-residue IL-8 was 2-fold less potent. A major finding was that NH2-terminal residues 4, 5, and 6 were absolutely essential for IL-8 activity and receptor binding. Quantitative dissociation of elastase release and chemotaxis activity was detected with 5-72, which compared with 1-72, was 80-fold less potent in the elastase assay, but was only slightly less potent in stimulating chemotaxis. IL-8 6-72 lacked all the biological activities tested but had detectable receptor binding activity. The NH2-terminal peptide, AVLPRSAKEL, lacked activity and receptor binding, suggesting that the NH2-terminal region alone is not sufficient for function. Comparison of analogs shortened at the COOH terminus showed that potency was progressively reduced as the COOH-terminal residues were excluded. However activity was retained in an analog (1-51) with the entire COOH-terminal alpha helix and beta turn missing. A peptide corresponding to the COOH-terminal 22 residues, although inactive alone, synergized with the 1-51 analog in stimulating elastase release. The results suggest that the NH2-terminal residues 4, 5, and 6, which are disordered in the IL-8 solution structure, are directly involved in receptor binding, but the COOH-terminal alpha helix is probably important for stabilizing the three-dimensional structure. Other regions within residues 7-51 are also functionally important.
Similar articles
- Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids.
Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. Clark-Lewis I, et al. J Biol Chem. 1994 Jun 10;269(23):16075-81. J Biol Chem. 1994. PMID: 8206907 - Amino-terminal processing of chemokine ENA-78 regulates biological activity.
Nufer O, Corbett M, Walz A. Nufer O, et al. Biochemistry. 1999 Jan 12;38(2):636-42. doi: 10.1021/bi981294s. Biochemistry. 1999. PMID: 9888803 - Neutrophil activation by monomeric interleukin-8.
Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. Rajarathnam K, et al. Science. 1994 Apr 1;264(5155):90-2. doi: 10.1126/science.8140420. Science. 1994. PMID: 8140420 - Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Clark-Lewis I, Moser B, Walz A, Baggiolini M, Scott GJ, Aebersold R. Clark-Lewis I, et al. Biochemistry. 1991 Mar 26;30(12):3128-35. doi: 10.1021/bi00226a021. Biochemistry. 1991. PMID: 2007144 - Structure-activity relationships of chemokines.
Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, Baggiolini M, Sykes BD. Clark-Lewis I, et al. J Leukoc Biol. 1995 May;57(5):703-11. doi: 10.1002/jlb.57.5.703. J Leukoc Biol. 1995. PMID: 7759949 Review.
Cited by
- Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview.
Matsushima K, Shichino S, Ueha S. Matsushima K, et al. Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(7):213-226. doi: 10.2183/pjab.99.014. Proc Jpn Acad Ser B Phys Biol Sci. 2023. PMID: 37518010 Free PMC article. Review. - Rational Design of de novo CCL2 Binding Peptides.
Davidoff Aguas E, Azizogli AR, Kashyap J, Dodd-O J, Siddiqui Z, Sy J, Kumar V. Davidoff Aguas E, et al. Adv Theory Simul. 2023 Feb;6(2):2200810. doi: 10.1002/adts.202200810. Epub 2022 Dec 18. Adv Theory Simul. 2023. PMID: 37122440 Free PMC article. - The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.
Cambier S, Gouwy M, Proost P. Cambier S, et al. Cell Mol Immunol. 2023 Mar;20(3):217-251. doi: 10.1038/s41423-023-00974-6. Epub 2023 Feb 1. Cell Mol Immunol. 2023. PMID: 36725964 Free PMC article. Review. - A Vegfc-Emilin2a-Cxcl8a Signaling Axis Required for Zebrafish Cardiac Regeneration.
El-Sammak H, Yang B, Guenther S, Chen W, Marín-Juez R, Stainier DYR. El-Sammak H, et al. Circ Res. 2022 Apr;130(7):1014-1029. doi: 10.1161/CIRCRESAHA.121.319929. Epub 2022 Mar 10. Circ Res. 2022. PMID: 35264012 Free PMC article. - A highly efficient method for the production and purification of recombinant human CXCL8.
McKenna S, Giblin SP, Bunn RA, Xu Y, Matthews SJ, Pease JE. McKenna S, et al. PLoS One. 2021 Oct 15;16(10):e0258270. doi: 10.1371/journal.pone.0258270. eCollection 2021. PLoS One. 2021. PMID: 34653205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources